Introduction
Iron deficiency anaemia (IDA) in pregnancy is one of the most prevalent nutritional disorders globally, significantly contributing to maternal morbidity, preterm birth, low birth weight, and impaired perinatal outcomes. Physiologically, pregnancy is associated with increased iron demand due to expansion of maternal blood volume, fetal growth, and placental development. In Ayurveda, maternal anaemia is correlated with Pandu Roga, a condition characterized by pallor, fatigue, weakness, dizziness, and reduced vitality. Among Ayurvedic formulations, Dhatrilauha is a classical iron-based preparation widely used in the management of Pandu, particularly in pregnancy due to its hematinic and rejuvenative properties.
Concept of Pandu Roga and maternal anaemia
Pandu Roga is primarily attributed to vitiation of Pitta dosha along with involvement of Vata and Kapha, leading to depletion of Rakta dhatu (blood tissue). The pathogenesis involves Agnimandya (impaired digestion), resulting in inadequate formation of nutritive plasma (Rasa dhatu) and subsequent poor hematopoiesis. Clinically, this manifests as pallor, fatigue, breathlessness, palpitations, and reduced physical endurance. This description closely parallels iron deficiency anaemia in modern medicine, where reduced hemoglobin synthesis leads to impaired oxygen transport and tissue hypoxia.
Composition and pharmacological basis of Dhatrilauha
- Dhatrilauha is a herbo-mineral formulation primarily composed of Loha bhasma (purified iron calx) processed with Amalaki (Emblica officinalis) and other herbal adjuvants.
- Amalaki is rich in vitamin C and polyphenols, which enhance iron absorption and provide antioxidant protection. The processed iron in Loha hasma is considered to be in a bio-assimilable form, facilitating gradual and sustained hematinic action.
- The synergistic combination ensures improved bioavailability while minimizing gastrointestinal irritation commonly associated with conventional iron therapy.
Mechanism of action in iron deficiency anaemia
- From an Ayurvedic perspective, Dhatrilauha acts by correcting Rakta dhatu kshaya (depletion of blood tissue) and enhancing Agni, thereby improving nutrient assimilation and tissue formation. The formulation is considered Rakta vardhaka (blood-enhancing), Pitta shamaka, and Rasayana, contributing to overall rejuvenation.
- From a modern pharmacological standpoint, Loha bhasma serves as a source of elemental iron, supporting hemoglobin synthesis and erythropoiesis.
- Amalaki enhances non-heme iron absorption through its high ascorbic acid content and reduces oxidative stress associated with iron supplementation. Additionally, antioxidant compounds help mitigate lipid peroxidation and cellular damage induced by iron deficiency.
Clinical applications in pregnancy
In pregnancy, Dhatrilauha is traditionally used for prevention and management of iron deficiency anaemia, especially in women intolerant to conventional oral iron salts. It is believed to improve haemoglobin levels, reduce fatigue, and enhance overall maternal vitality. Its gentle action on the gastrointestinal tract makes it suitable for long-term use under medical supervision. It is often administered along with dietary modifications and other Pandu-hara formulations.
Safety and considerations
While Dhatrilauha is generally considered safe in therapeutic doses, standardized preparation and appropriate clinical supervision are essential, particularly during pregnancy. Quality control of bhasma preparation is critical to ensure safety and prevent heavy metal toxicity. Individualized dosing based on Prakriti (constitution) and disease severity is recommended.
Conclusion
Dhatrilauha represents a classical Ayurvedic iron formulation with significant therapeutic potential in the management of iron deficiency anaemia during pregnancy. Its dual mechanism of enhancing hematopoiesis and improving iron bioavailability aligns with both Ayurvedic principles and modern nutritional science. While traditional usage supports its efficacy and safety, further well-designed clinical studies are required to validate its role as an integrative therapy in maternal anaemia management.1
References:
- Roy A, Dwivedi M. Dhatrilauha: Right choice for iron deficiency anemia in pregnancy. Ayu. 2014;35(3):283-288. doi:10.4103/0974-8520.153745 https://pmc.ncbi.nlm.nih.gov/articles/PMC4427833/